Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

The formulated gel is a promising treatment for alopecia areata.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

A new compound shows promise as a topical treatment for hair loss.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Baricitinib may effectively treat oral lichen planus.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Spanlastics effectively deliver Rizatriptan Benzoate with high efficiency and controlled release.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Betamethasone oral mini-pulse therapy showed good or fair results in treating lichen planus.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.